Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants.
Cohen-Wolkowiez M, Sampson M, Bloom BT, Arrieta A, Wynn JL, Martz K, Harper B, Kearns GL, Capparelli EV, Siegel D, Benjamin DK Jr, Smith PB; Best Pharmaceuticals for Children Act–Pediatric Trials Network. Cohen-Wolkowiez M, et al. Among authors: capparelli ev. Pediatr Infect Dis J. 2013 Sep;32(9):956-61. doi: 10.1097/INF.0b013e3182947cf8. Pediatr Infect Dis J. 2013. PMID: 23587979 Free PMC article. Clinical Trial.
Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants.
Capparelli EV, Sullivan JL, Mofenson L, Smith E, Graham B, Britto P, Becker MI, Holland D, Connor JD, Luzuriaga K; Pediatric ACTG 356 Investigators. Capparelli EV, et al. Pediatr Infect Dis J. 2001 Aug;20(8):746-51. doi: 10.1097/00006454-200108000-00006. Pediatr Infect Dis J. 2001. PMID: 11734735 Clinical Trial.
Pharmacokinetics and tolerance of zidovudine in preterm infants.
Capparelli EV, Mirochnick M, Dankner WM, Blanchard S, Mofenson L, McSherry GD, Gay H, Ciupak G, Smith B, Connor JD; Pediatric AIDS Clinical Trials Group 331 Investigators. Capparelli EV, et al. J Pediatr. 2003 Jan;142(1):47-52. doi: 10.1067/mpd.2003.mpd0335. J Pediatr. 2003. PMID: 12520254 Clinical Trial.
Pharmacokinetics of gatifloxacin in infants and children.
Capparelli EV, Reed MD, Bradley JS, Kearns GL, Jacobs RF, Damle BD, Blumer JL, Grasela DM. Capparelli EV, et al. Antimicrob Agents Chemother. 2005 Mar;49(3):1106-12. doi: 10.1128/AAC.49.3.1106-1112.2005. Antimicrob Agents Chemother. 2005. PMID: 15728910 Free PMC article. Clinical Trial.
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
Kovacs A, Cowles MK, Britto P, Capparelli E, Fowler MG, Moye J, McIntosh K, Rathore MH, Pitt J, Husson RN. Kovacs A, et al. Pediatr Infect Dis J. 2005 Jun;24(6):503-9. doi: 10.1097/01.inf.0000164787.63237.0b. Pediatr Infect Dis J. 2005. PMID: 15933559 Clinical Trial.
Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants.
Capparelli EV, Bloom BT, Kueser TJ, Oelberg DG, Bifano EM, White RD, Schelonka RL, Pearlman SA, Patti J, Hetherington SV. Capparelli EV, et al. Antimicrob Agents Chemother. 2005 Oct;49(10):4121-7. doi: 10.1128/AAC.49.10.4121-4127.2005. Antimicrob Agents Chemother. 2005. PMID: 16189088 Free PMC article.
Population pharmacokinetic model for gatifloxacin in pediatric patients.
Rubino CM, Capparelli EV, Bradley JS, Blumer JL, Kearns GL, Reed M, Jacobs RF, Cirincione B, Grasela DM. Rubino CM, et al. Among authors: capparelli ev. Antimicrob Agents Chemother. 2007 Apr;51(4):1246-52. doi: 10.1128/AAC.00685-06. Epub 2007 Jan 12. Antimicrob Agents Chemother. 2007. PMID: 17220409 Free PMC article.
411 results